Kenya to Save 60% on Essential Medicines Under New Ministry of Health–Pfizer Accord

𝐍𝐚𝐢𝐫𝐨𝐛𝐢, 𝐊𝐞𝐧𝐲𝐚 - 𝐉𝐮𝐧𝐞 𝟐4, 𝟐𝟎𝟐𝟓

Kenya will save up to 60% on essential medicines for diabetes, cancer, and infectious diseases under the newly launched Kenya–Pfizer Accord—an initiative aimed at expanding access to affordable, high-quality treatment within the public health system. The landmark agreement was officially unveiled in Nairobi by the Principal Secretary for Medical Services, Dr. Ouma Oluga, and Mr. Nick Lagunowich, Pfizer’s Global President for Emerging Markets.

The Ministry of Health, in partnership with Pfizer, has positioned the Accord as a transformative step toward Universal Health Coverage (UHC) by reducing the cost burden on patients and ensuring equitable access to life-saving therapies. Kenya will now access over 140 medicines on a not-for-profit basis, with some treatments priced drastically. 

“We are signing this Accord to reduce the cost burden on our patients and ensure lifesaving treatments are within reach for all,” said Dr. Oluga. “This is a bold step in delivering health equity, especially for those who rely on the public health system.”

The Principal Secretary also underscored the importance of investing in the health workforce. He noted that the Ministry will be rolling out competence-based in-service training to retrain healthcare workers, reduce negligence, and strengthen the delivery of quality patient care. Access to clinical trials and expanded research infrastructure is also being prioritized to foster local innovation and support evidence-based practice.

Reforms such as the establishment of the Social Health Authority and a new health law on quality care—currently under public participation—are expected to anchor these initiatives and ensure the long-term sustainability of Kenya’s health system. Dr. Oluga emphasized that these reforms aim to protect Kenyan families from financial hardship and deliver care that is both accessible and affordable.

Pfizer’s Nick Lagunowich commended the Ministry for its vision and leadership. “This Accord reflects our shared belief that everyone should have access to quality medicines, regardless of their income or location. We are proud to partner with Kenya in advancing sustainable health outcomes,” he said.

The partnership is expected to strengthen system resilience, build long-term capacity, and support Kenya’s ongoing journey toward equitable and inclusive healthcare.